Biofrontera Inc. Quarterly Deferred Federal Income Tax Expense (Benefit) in USD from Q2 2021 to Q1 2023
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.
-
Summary
-
Biofrontera Inc. annual/quarterly Deferred Federal Income Tax Expense (Benefit) history and growth rate from Q2 2021 to Q1 2023.
- Biofrontera Inc. Deferred Federal Income Tax Expense (Benefit) for the quarter ending March 31, 2023 was $0.000.
- Biofrontera Inc. Deferred Federal Income Tax Expense (Benefit) for the twelve months ending March 31, 2023 was $0.000.
- Biofrontera Inc. annual Deferred Federal Income Tax Expense (Benefit) for 2023 was $0.000.
Deferred Federal Income Tax Expense (Benefit), Trailing 12 Months (USD)
Deferred Federal Income Tax Expense (Benefit), Quarterly (USD)